PRTN3 and interstitial lung disease: On the basis of the contribution rates of the candidate variables in model 1 by PCA, eight variables were selected with 91% of total contribution rates: MPO-ANCA, PR3-ANCA, ENT symptoms, nervous system symptoms, general symptoms, renal symptoms, cutaneous symptoms, and ILD (Supplementary Table S3).